Persistent Corneal Epithelial Defect Clinical Trial
Official title:
The Use of Autologous Platelet Lysate in Persistent Corneal Epithelial Defects
Patients diagnosed with persistent corneal epithelial ulcers will be treated with autologous platelet lysate.
Autologous platelet lysate (PL) will be given to patients diagnosed with persistent corneal epithelial ulcers (PED) who are unresponsive to conventional therapy to promote the healing of PED. PL will be dispensed into sterile eye droppers, and these eye droppers will be stored ideally at -20C and thaw once for use, then will be kept in the refrigerator at +4C, to be taken in multiple doses. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00988494 -
Study of DE-105 Ophthalmic Solution in Patients With Persistent Corneal Epithelial Defect
|
Phase 2 | |
Completed |
NCT03687632 -
ST266 Eye Drops for the Treatment of Persistent Corneal Epithelial Defects
|
Phase 2 | |
Recruiting |
NCT05966493 -
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED
|
Phase 2/Phase 3 | |
Completed |
NCT05436288 -
A Study of the KIO-201 (Ocular Bandage Gel) for Improving Persistent Corneal Epithelial Defects
|
Phase 2 | |
Recruiting |
NCT05727878 -
Trial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCED
|
Phase 2 | |
Terminated |
NCT05066698 -
ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects
|
Phase 2 | |
Withdrawn |
NCT05172349 -
Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Trophic Ulcers
|
Phase 2 |